Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford’s genetic expertise is centred around using genetic information to better understand phenotypic and mechanistic aspects of disease, as well as integrating the use of genetic information in the detection, diagnosis and treatment of cancer. Applying this to the challenges of cancer takes many forms, such as identifying novel pathways that contribute to tumour behaviour, how germline mutations can affect an individual’s risk of cancer, and how a tumour’s genetics influence how it responds to treatment.